進階篩選

Technical category
    • 百發百中、相醫維命 – 發展伴隨式診斷以進行小分子RNA干擾片段的癌症精準醫療

      Precision Health Ecosystem FutureTech 百發百中、相醫維命 – 發展伴隨式診斷以進行小分子RNA干擾片段的癌症精準醫療

      Cancer is the first leading cause of death in Taiwan. Targeted therapy allows the cancer cells to be specifically targeted, reduces the side effects,achieves the purpose of precision cancer treatment. This report contains two invention technologies which combined early & specific diagnosis of a specific Aurora-A mRNA isoform in cancers (the companion diagnosis)the treated with a selective locked nucleic acid (LNA)-modified novel double-stranded short interfering nucleic acid (siRNA) to inhibit the translation of this Aurora-A mRNA isoform (targeted therapy) in cancers.
    • Rapid diagnostic device for monitoring the abnormal growth of the endometrial tissue

      Medical Devices FutureTech Rapid diagnostic device for monitoring the abnormal growth of the endometrial tissue

      This rapid diagnostic device for monitoring the abnormal growth of the endometrial tissue is expected to allow women to detect whether VEGFIL-6 are too high at home in a simplerapid manner. These two factors are also increasing in some gynecological cancers. Through the new device, it is convenient for women to self-monitoring women physiologically-relevant diseasespossible causes of abnormal bleeding in the future,seek appropriate medical treatment early.
  • 1